News
IQV
236.64
+2.29%
5.30
Weekly Report: what happened at IQV last week (0415-0419)?
Weekly Report · 1d ago
Bank of America Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
TipRanks · 5d ago
Press Release: IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
IQVIA to announce its first-quarter 2024 financial results on May 2, 2024. The company will also host a conference call and webcast at 9:00 a.m. Eastern Time. IQVIA is a leading provider of advanced analytics, technology solutions to the life sciences industry.
Dow Jones · 04/15 20:20
Weekly Report: what happened at IQV last week (0408-0412)?
Weekly Report · 04/15 09:16
AbbVie keeps Humira market share near 100% despite biosimilars: report
Healthcare AbbVie keeps Humira market share near 100% despite biosimilars: report. Humira is the world's bestselling drug for the 10th year in a row. Amgen launched the first biosimilar version of the arthritis drug in the U.S. Last year.
Seeking Alpha · 04/13 14:52
IQVIA HOLDINGS INC <IQV.N>: MIZUHO RAISES TARGET PRICE TO $277 FROM $268
Reuters · 04/11 11:46
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?
IQVIA Holdings Inc. Carries debt of US$13.7b. The company's balance sheet shows that it is in a good position to manage its debt levels. IQVIA has a debt to EBITDA ratio of 4.5 and its free cash flow is higher than its debt. The balance sheet is a good place to look at to assess a company's ability to manage debt. IQvIA Holdings grew its EBIT at 11% over the last 12 months. The stock has a warning sign of 2 warning signs for companies with heavy debt.
Simply Wall St · 04/11 11:02
U.S. RESEARCH ROUNDUP-Airbnb, Albemarle, Biogen
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Airbnb, Albemarle and Biogen among those with revised targets. AIG, Aflac and Allstate among companies with new targets for the day. Analysts cut target prices on some of the companies.
Reuters · 04/11 07:32
Global Stock leaders for 2030 in Health Tech - UBS
UBS highlights companies in the greentech, enabling tech, fintech, and healthtech sectors. The need for waste reduction and efficiency could be catalysts for rising healthcare spending. When it comes to healthtech, spending as a percentage of global GDP is almost 11%. UBS lists these global stocks as leaders in the healthtech space.
Seeking Alpha · 04/10 17:49
IQVIA Holdings (IQV) Gets a Buy from Barclays
TipRanks · 04/10 06:47
Oakmark Global Select Fund: First Calendar Quarter 2024
The Oakmark Global Select Fund returned 2.95% for the quarter, underperforming the MSCI World Index. Charter Communications was a top detractor during the first quarter. The fund purchased new positions in Reckitt Benckiser Group, IQVIA Holdings and Centene.
Seeking Alpha · 04/10 06:20
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
Salesforce announced expanded global partnership with IQVIA Holdings, Inc. To aid development of its Life Sciences Cloud. The companies will collaborate to facilitate the development of the company's customer engagement software. The company says the new product is expected to be available in 2025. Salesforce shares are trading higher today.
Benzinga · 04/09 14:03
Truist Financial Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
TipRanks · 04/09 11:35
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
NASDAQ · 04/09 10:20
IQVIA and Salesforce Expand Global Partnership To Accelerate The Development Of Life Sciences Cloud
IQVIA and Salesforce announce expanded global strategic partnership to accelerate development of Salesforce's Life Sciences Cloud. The partnership will provide customers with a single, end-to-end engagement platform for the life sciences industry. Salesforce will apply innovations from IQVIA's OCE CRM to the new platform.
Benzinga · 04/08 20:01
IQVIA HOLDINGS - PARTIES WILL COLLABORATE TO ACCELERATE DEVELOPMENT OF LIFE SCIENCES CLOUD FOR CUSTOMER ENGAGEMENT, EXPECTED TO BE AVAILABLE IN 2025
Reuters · 04/08 20:01
Weekly Report: what happened at IQV last week (0401-0405)?
Weekly Report · 04/08 09:17
AbbVie’s Humira outperforms forcing biosimilar maker to cut sales staff
German drugmaker Boehringer Ingelheim to reduce its U.S. Salesforce. Biosimilars targeting AbbVie's blockbuster arthritis therapy, Humira, have lagged expectations. The company says sales for its off-patent versions have underwhelmed.
Seeking Alpha · 04/05 12:30
U.S. RESEARCH ROUNDUP-Ally Financial, GE Vernova, Navient
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Ally Financial, GE Vernova, Navient and Navient are among the companies. Analysts cut ratings and target prices on several companies on Wednesday. Some analysts raised their targets for the companies, others cut them.
Reuters · 04/03 07:28
Weekly Report: what happened at IQV last week (0325-0329)?
Weekly Report · 04/01 09:16
More
Webull provides a variety of real-time IQV stock news. You can receive the latest news about Iqvia Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About IQV
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.